Kyung Nam Pharm Co Ltd (053950) - Total Assets
Based on the latest financial reports, Kyung Nam Pharm Co Ltd (053950) holds total assets worth ₩176.00 Billion KRW (≈ $119.28 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Kyung Nam Pharm Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Kyung Nam Pharm Co Ltd - Total Assets Trend (2007–2025)
This chart illustrates how Kyung Nam Pharm Co Ltd's total assets have evolved over time, based on quarterly financial data. See Kyung Nam Pharm Co Ltd (053950) shareholders funds for net asset value and shareholders' equity analysis.
Kyung Nam Pharm Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Kyung Nam Pharm Co Ltd's total assets of ₩176.00 Billion consist of 51.1% current assets and 49.0% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 4.0% |
| Accounts Receivable | ₩15.07 Billion | 9.7% |
| Inventory | ₩12.40 Billion | 8.0% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩210.05 Million | 0.1% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2007–2025)
This chart illustrates how Kyung Nam Pharm Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 053950 company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kyung Nam Pharm Co Ltd's current assets represent 51.1% of total assets in 2025, an increase from 0.0% in 2007.
- Cash Position: Cash and equivalents constituted 4.0% of total assets in 2025, down from 33.5% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 9.7% of total assets.
Kyung Nam Pharm Co Ltd Competitors by Total Assets
Key competitors of Kyung Nam Pharm Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
Kyung Nam Pharm Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.75 | 1.76 | 1.65 |
| Quick Ratio | 1.46 | 1.44 | 1.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩37.00 Billion | ₩31.14 Billion | ₩21.60 Billion |
Kyung Nam Pharm Co Ltd - Advanced Valuation Insights
This section examines the relationship between Kyung Nam Pharm Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.27 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -6.6% |
| Total Assets | ₩155.63 Billion |
| Market Capitalization | $10.26K USD |
Valuation Analysis
Below Book Valuation: The market values Kyung Nam Pharm Co Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Kyung Nam Pharm Co Ltd's assets decreased by 6.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Kyung Nam Pharm Co Ltd (2007–2025)
The table below shows the annual total assets of Kyung Nam Pharm Co Ltd from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩155.63 Billion ≈ $105.47 Million |
-6.58% |
| 2024-12-31 | ₩166.58 Billion ≈ $112.89 Million |
-0.02% |
| 2023-12-31 | ₩166.61 Billion ≈ $112.91 Million |
+20.50% |
| 2022-12-31 | ₩138.27 Billion ≈ $93.70 Million |
+9.17% |
| 2020-12-31 | ₩126.66 Billion ≈ $85.83 Million |
+70.10% |
| 2019-12-31 | ₩74.46 Billion ≈ $50.46 Million |
+40.08% |
| 2018-12-31 | ₩53.16 Billion ≈ $36.02 Million |
+17.67% |
| 2016-12-31 | ₩45.18 Billion ≈ $30.61 Million |
-49.35% |
| 2010-12-31 | ₩89.20 Billion ≈ $60.45 Million |
-2.53% |
| 2009-12-31 | ₩91.51 Billion ≈ $62.01 Million |
+40.67% |
| 2008-12-31 | ₩65.05 Billion ≈ $44.08 Million |
+40.20% |
| 2007-12-31 | ₩46.40 Billion ≈ $31.44 Million |
-- |
About Kyung Nam Pharm Co Ltd
Kyung Nam Pharm Co.,Ltd. manufactures pharmaceuticals. The company offers over-the-counter products, including antipyretics, analgesics, and antiphlogistics; medications for skin diseases and athlete's foot; pain relief patches/creams, antitussives, mucolytic agents, and expectorants; gastro protective agents/digestives; periodontal/gum disease drugs; medications for liver diseases; ear and nose … Read more